We therefore speculate that the elevated levels of plasma BNP in the AF cohort denote latent structural heart diseases such as subclinical cardiac dysfunction, including mildly elevated intracardiac pressure and volume, and myocardial ischemia, thus these individuals are prone to be at risk for heart failure and coronary heart disease. This evidence concerns the gene NPPB and myocardial ischemia.